ANDY CORAVOS

Andy Coravos stands out as a visionary leader and entrepreneur at the forefront of health technology. As the CEO of HumanFirst, she is dedicated to building infrastructure that enables the safe and effective use of digital measures in clinical research and care. Her leadership at HumanFirst centers on creating a robust platform for evaluating, deploying, and monitoring digital health technologies, ultimately accelerating the development of new treatments and improving patient outcomes.

Prior to HumanFirst, Andy co-founded and served as CEO of Elektra Labs, a company focused on curating and evaluating digital biomarkers and digital health tools. Elektra Labs played a crucial role in establishing best practices and standards for digital health product development, a mission that continues within HumanFirst after its acquisition. Her career background is deeply rooted in technology and healthcare, with a strong emphasis on data privacy and regulatory science. She holds degrees from MIT, where she developed a foundational understanding of complex systems and data analysis, which she has since applied to the intricate challenges of healthcare innovation.

Andy's investment focus, both personally and through her entrepreneurial endeavors, lies in areas that promise to transform healthcare delivery and research. This includes digital health solutions, particularly those involving remote patient monitoring, decentralized clinical trials, and the ethical application of artificial intelligence and machine learning in medicine. She is a staunch advocate for robust data privacy frameworks and regulatory clarity to foster innovation while protecting patient interests. Her work often involves collaborating with regulatory bodies like the FDA to shape policies that support the responsible adoption of new technologies.

While Andy Coravos is primarily known as a founder and operator, her influence extends to advising and championing companies that align with her vision for a more data-driven and patient-centric healthcare system. Her notable contributions include not just the companies she has built, but also her thought leadership in shaping industry standards and best practices for digital health. She is a frequent speaker and contributor to discussions on the future of medicine, emphasizing the critical intersection of technology, ethics, and regulatory compliance. Her work continues to drive significant advancements in how digital tools are integrated into healthcare, making her a pivotal figure in the evolving health tech landscape.